Signaling Pathways - Stem Cell Differentiation - Mixed lineage kinase domain-like protein (MLKL) - JAK - Bcr-Abl
清除全部
-
B5954 Dasatinib Monohydrate中文名: 达沙替尼一水合物Target: PDGFR|c-Kit|Bcr-Abl|SrcSummary: ABL\SRC\KIT\PDGFR以及其它酪氨酸激酶抑制剂 -
B5846 Radotinib(IY-5511)中文名: 雷多替尼Target: PDGFR|Bcr-AblSummary: Bcr-Abl酪氨酸激酶抑制剂 -
B8023 Cerdulatinib (PRT062070)Target: JAK|Syk|TYK2Summary: Syk/JAK抑制剂 -
B7731 Necrosulfonamide1 CitationTarget: Mixed lineage kinase domain-like protein (MLKL)Summary: 坏死抑制剂 -
B7700 IQ 1Target: Stem Cell Differentiation|PP2A/Nkd interactionSummary: 维持胚胎干细胞（ESC）的多能性 -
B1130 GLPG06341 Citation中文名: 菲戈替尼Target: JAKSummary: JAK1抑制剂 -
B2171 Imatinib (STI571)中文名: 伊马替尼Target: PDGFR|c-Kit|Bcr-AblSummary: 蛋白酪氨酸激酶抑制剂 -
B1299 1-NM-PP1Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-FynSummary: Pp60c-src抑制剂 -
B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂 -
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂